<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Hemoglobin</journal-id>
      <journal-id journal-id-type="iso-abbrev">Hemoglobin</journal-id>
      <journal-id journal-id-type="publisher-id">hem</journal-id>
      <journal-title-group>
        <journal-title>Hemoglobin</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0363-0269</issn>
      <issn pub-type="epub">1532-432X</issn>
      <publisher>
        <publisher-name>Informa Healthcare USA, Inc.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24351118</article-id>
      <article-id pub-id-type="pmc">3971804</article-id>
      <article-id pub-id-type="doi">10.3109/03630269.2013.863206</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Severe &#x3B1;-Thalassemia Intermedia Due to a Compound Heterozygosity for the Highly Unstable Hb Adana (<italic>HBA2</italic>: c.179G&gt;A) and a Novel Codon 24 (<italic>HBA2</italic>: c.75T&gt;A) Mutation</article-title>
      </title-group>
      <contrib-group>
        <contrib id="a1" contrib-type="author">
          <name>
            <surname>Megawati</surname>
            <given-names>Dewi</given-names>
          </name>
          <xref ref-type="aff" rid="end-a1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="end-a2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="a2" contrib-type="author">
          <name>
            <surname>Nainggolan</surname>
            <given-names>Ita M.</given-names>
          </name>
          <xref ref-type="aff" rid="end-a1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="end-a2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="a3" contrib-type="author">
          <name>
            <surname>Swastika</surname>
            <given-names>Maria</given-names>
          </name>
          <xref ref-type="aff" rid="end-a1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="a4" contrib-type="author">
          <name>
            <surname>Susanah</surname>
            <given-names>Susi</given-names>
          </name>
          <xref ref-type="aff" rid="end-a3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="a5" contrib-type="author">
          <name>
            <surname>Mose</surname>
            <given-names>Johanes C.</given-names>
          </name>
          <xref ref-type="aff" rid="end-a4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="a6" contrib-type="author">
          <name>
            <surname>Harahap</surname>
            <given-names>Alida R.</given-names>
          </name>
          <xref ref-type="aff" rid="end-a1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="end-a5">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="a7" contrib-type="author" corresp="yes">
          <name>
            <surname>Setianingsih</surname>
            <given-names>Iswari</given-names>
          </name>
          <xref ref-type="aff" rid="end-a1">
<sup>1</sup>
</xref>
        </contrib>
        <aff id="end-a1">
          <sup>1</sup>
          <institution>The Eijkman Institute for Molecular Biology</institution>
          <addr-line>Jakarta</addr-line>
          <country>Indonesia</country>
        </aff>
        <aff id="end-a2">
          <sup>2</sup>
          <institution>Biomedical Sciences Faculty of Medicine, Universitas Indonesia</institution>
          <addr-line>Jakarta</addr-line>
          <country>Indonesia</country>
        </aff>
        <aff id="end-a3">
          <sup>3</sup>
          <institution>Department of Pediatric Hematogy-Oncology, Hasan Sadikin General Hospital/Faculty of Medicine Padjajaran University</institution>
          <addr-line>Bandung</addr-line>
          <country>Indonesia</country>
        </aff>
        <aff id="end-a4">
          <sup>4</sup>
          <institution>Department of Obstetric-Gynecology, Hasan Sadikin General Hospital/Faculty of Medicine Padjajaran University</institution>
          <addr-line>Bandung</addr-line>
          <country>Indonesia</country>
        </aff>
        <aff id="end-a5">
          <sup>5</sup>
          <institution>Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia</institution>
          <addr-line>Jakarta</addr-line>
          <country>Indonesia</country>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Address correspondence to <addr-line>Dr. Iswari Setianingsih</addr-line><institution>Eijkman Institute for Molecular Biology</institution><addr-line>Jl. Diponegoro No. 69. Jakarta 14030</addr-line><country>Indonesia</country>; Tel: <phone>+62-21-314-8695</phone>; Fax: <fax>+62-21-314-7982</fax>; E-mail: <email xlink:href="ning@eijkman.go.id">ning@eijkman.go.id</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <volume>38</volume>
      <issue>2</issue>
      <fpage>149</fpage>
      <lpage>151</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>2</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>8</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2014 Informa Healthcare USA, Inc. All rights reserved: reproduction in whole or part not permitted</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by-nc/3.0/" license-type="open-access">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>HBA2</title>
          <p>We report a novel mutation at codon 24 of the &#x3B1;2-globin gene (<italic>HBA2</italic>: c.75T&#x2009;&gt;&#x2009;A) found in a Sundanese family. This novel mutation was detected during prenatal diagnosis. The couple already had a 7-year-old boy who exhibited clinically severe &#x3B1;-thalassemia intermedia (&#x3B1;-TI), and he was found to be a compound heterozygote for the novel mutation at codon 24 and the previously described Hb Adana (<italic>HBA2</italic>: c.179G&#x2009;&gt;&#x2009;A) at codon 59 of the &#x3B1;2-globin gene. The father was a carrier of the novel point mutation and showed normal hemoglobin (Hb) and a low mean corpuscular volume (MCV) and mean corpuscular Hb (MCH) value.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>&#x3B1;-globin gene</kwd>
        <kwd>&#x3B1;-Thalassemia (&#x3B1;-thal)</kwd>
        <kwd>nonsense mutation</kwd>
        <kwd>point mutation</kwd>
        <kwd>prenatal diagnosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>&#x3B1;-Thalassemia (&#x3B1;-thal) is an autosomal recessive disorder, characterized by microcytic hypochromic red blood cells with eventual mild anemia in the healthy carrier (<xref rid="b1" ref-type="bibr">1</xref>). The defect is mostly caused by large &#x3B1;-globin gene deletions that abolish the expression of one or more &#x3B1;-globin genes, causing mild conditions such as &#x3B1;<sup>+</sup> heterozygosity (&#x2013;&#x3B1;/&#x3B1;&#x3B1;), homozygosity (&#x2013;&#x3B1;/&#x2013;&#x3B1;) or &#x3B1;<sup>0</sup> heterozygosity (&#x2013;&#x2009;&#x2013;/&#x3B1;&#x3B1;). More severe conditions are Hb H disease (&#x2013;&#x3B1;/&#x2013;&#x2009;&#x2013;) and Hb Bart&#x2019;s hydrops fetalis (&#x2013;&#x2009;&#x2013;/&#x2013;&#x2009;&#x2013;), the latter being lethal during fetal life because no &#x3B1;-globin genes are expressed (<xref rid="b2" ref-type="bibr">2</xref>).</p>
    <p>Although nondeletional &#x3B1;-thal is less frequent compared to the large deletion types, it is commonly manifested as more severe phenotypes because the mutations are mostly associated with protein stability (<xref rid="b3" ref-type="bibr">3</xref>). The severity is also determined by the localization of the mutation on the &#x3B1;-globin gene (&#x3B1;2 or &#x3B1;1). As previously reported by Liebhaber <italic>et al.</italic> (<xref rid="b4" ref-type="bibr">4</xref>), the &#x3B1;2-globin gene is predominantly expressed, 2- to 3-fold higher than the &#x3B1;1-globin gene. Recently, a mild thalassemia syndrome due to compound heterozygosity for the codon 24 (<italic>HBA2</italic>: c.75T&#x2009;&gt;&#x2009;G) of the &#x3B1;2-globin gene and a single &#x3B1;-globin gene deletion were described in a Surinamase patient (<xref rid="b5" ref-type="bibr">5</xref>). Here we report a different mutation at the same codon 24 (<italic>HBA2</italic>: c.75T&#x2009;&gt;&#x2009;A).</p>
    <p>A Sundanese Indonesian couple was referred to our clinic (Yayasan GenNeka, Eijkman Institute for Molecular Biology, Jakarta, Indonesia) for prenatal diagnosis because their second child (II-2) has been affected with severe &#x3B1;-thal intermedia (&#x3B1;-TI) and has been receiving blood transfusions regularly every 4-8 weeks since he was 3 years old. The first child (II-1) has not been studied yet, but no clinical complaints have been reported. The pedigree of the family is depicted in <xref ref-type="fig" rid="f1">Figure 1</xref>.<fig fig-type="figure" id="f1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Pedigree of the family. The codon 59 (<italic>HBA2</italic>: c.179G&#x2009;&gt;&#x2009;A) mutation was found in the mother (I-1), the second child (II-2) and the fetus (II-3), whereas the novel codon 24 (<italic>HBA2</italic>: c.75T&#x2009;&gt;&#x2009;A) mutation was carried by the father (I-2) and in compound heterozygosity by the second child (II-2).</p></caption><graphic xlink:href="HEM-38-149-g001"/></fig>
</p>
    <p>Hematology profiles of the couples were consistent with &#x3B1;-thal carriers. DNA analysis for the parents was carried out using routine multiplex polymerase chain reaction (m-PCR) to detect the common deletions found in Indonesia: Southeast Asian (&#x2013;&#x2009;&#x2013;<sup>SEA</sup>/), Thailand (&#x2013;&#x2009;&#x2013;<sup>THAI</sup>/), Filipino (&#x2013;&#x2009;&#x2013;<sup>FIL</sup>/) (<xref rid="b6" ref-type="bibr">6</xref>), the 3.7&#x2009;kb (rightward) (&#x2013;&#x3B1;<sup>3.7</sup>/) and 4.2&#x2009;kb (leftward) (&#x2013;&#x3B1;<sup>4.2</sup>/) (<xref rid="b7" ref-type="bibr">7</xref>). None of the common deletions were detected; therefore, DNA analysis was performed using the PCR-RFLP (restriction fragment length polymorphism) method (<xref rid="b8" ref-type="bibr">8</xref>) to detect the codon 59 (<italic>HBA2</italic>: c.179G&#x2009;&gt;&#x2009;A) of the &#x3B1;2-globin gene and Hb Constant Spring (Hb CS or <italic>HBA2</italic>: c.427T&#x2009;&gt;&#x2009;C) (<xref rid="b9" ref-type="bibr">9</xref>), the two most common point mutations found in the Indonesian population. The mother was detected to be a carrier of codon 59, while the father was normal for both point mutations. DNA analysis of the father was continued using the multiplex ligation-dependent probe amplification (MLPA) technique (P140 HBA; MRC Holland, Amsterdam, The Netherlands) to detect deletion or duplication of the &#x3B1;-globin gene cluster [including the hypersensitive-40 (HS-40) region until the &#x3B8;-globin gene], but no abnormalities were found. Then both &#x3B1;-globin genes were amplified by PCR and analyzed by direct sequencing (<xref rid="b10" ref-type="bibr">10</xref>,<xref rid="b11" ref-type="bibr">11</xref>) using the BigDye&#x2122; Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) on the ABI PRISM&#x2122; 3130 Genetic Analyzer (Applied Biosystems). Sequencing results revealed that the father was heterozygous for the novel mutation at codon 24 of the &#x3B1;2-globin gene (<xref ref-type="fig" rid="f2">Figure 2</xref>). The clinical and molecular data are summarized in <xref ref-type="table" rid="t1">Table 1</xref>.<fig fig-type="figure" id="f2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Sequencing result of the &#x3B1;2-globin gene in the father showing heterozygosity for codon 24 (<italic>HBA2</italic>: c.75T&#x2009;&gt;&#x2009;A).</p></caption><graphic xlink:href="HEM-38-149-g002"/></fig>
<table-wrap id="t1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Summary of the Hematological Profile and Molecular Findings of the Family.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">I-2</th><th align="center" rowspan="1" colspan="1">I-1<xref ref-type="fn" rid="T1-F1"><sup>a</sup></xref>
</th><th align="center" rowspan="1" colspan="1">II-2<xref ref-type="fn" rid="T1-F2"><sup>b</sup></xref>
</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">Sex-age</td><td rowspan="1" colspan="1">M-37</td><td rowspan="1" colspan="1">F-36</td><td rowspan="1" colspan="1">M-7</td></tr><tr><td rowspan="1" colspan="1">Hb (g/dL)</td><td char="." rowspan="1" colspan="1">15.5</td><td char="." rowspan="1" colspan="1">11.8</td><td char="." rowspan="1" colspan="1">10.0</td></tr><tr><td rowspan="1" colspan="1">RBC (10<sup>12</sup>/L)</td><td char="." rowspan="1" colspan="1">5.55</td><td char="." rowspan="1" colspan="1">5.04</td><td char="." rowspan="1" colspan="1">4.15</td></tr><tr><td rowspan="1" colspan="1">MCV (fL)</td><td char="." rowspan="1" colspan="1">77.2</td><td char="." rowspan="1" colspan="1">68.8</td><td char="." rowspan="1" colspan="1">69.2</td></tr><tr><td rowspan="1" colspan="1">MCH (pg)</td><td char="." rowspan="1" colspan="1">27.3</td><td char="." rowspan="1" colspan="1">23.4</td><td char="." rowspan="1" colspan="1">24.1</td></tr><tr><td rowspan="1" colspan="1">MCHC (g/dL)</td><td char="." rowspan="1" colspan="1">35.4</td><td char="." rowspan="1" colspan="1">34.0</td><td char="." rowspan="1" colspan="1">34.8</td></tr><tr><td rowspan="1" colspan="1">RDW (%)</td><td char="." rowspan="1" colspan="1">13.7</td><td char="." rowspan="1" colspan="1">14.4</td><td char="." rowspan="1" colspan="1">32.0</td></tr><tr><td rowspan="1" colspan="1">Hb A<sub>2</sub> (%)</td><td char="." rowspan="1" colspan="1">2.5</td><td char="." rowspan="1" colspan="1">2.8</td><td char="." rowspan="1" colspan="1">2.6</td></tr><tr><td rowspan="1" colspan="1">Hb F (%)</td><td char="." rowspan="1" colspan="1">0.9</td><td char="." rowspan="1" colspan="1">0.3</td><td char="." rowspan="1" colspan="1">1.6</td></tr><tr><td rowspan="1" colspan="1">&#x3B1; Genotype</td><td rowspan="1" colspan="1">&#x3B1;<sup>codon 24</sup>&#x3B1;/&#x3B1;&#x3B1;</td><td rowspan="1" colspan="1">&#x3B1;<sup>codon 59</sup>&#x3B1;/&#x3B1;&#x3B1;</td><td rowspan="1" colspan="1">&#x3B1;<sup>codon 24</sup>&#x3B1;/&#x3B1;<sup>codon 59</sup>&#x3B1;</td></tr></tbody></table><table-wrap-foot><fn id="T1-F1"><p>
<sup>a</sup>Mother was 23 weeks pregnant at the time of the study.</p></fn><fn id="T1-F2"><p>
<sup>b</sup>The hematological parameters of the affected child (II-2) are post transfusion.</p></fn></table-wrap-foot></table-wrap>
</p>
    <p>Amniocentesis was performed for prenatal diagnosis and DNA was extracted from the amniotic fluid. A 2&#x2009;mL amount out of 15&#x2009;mL of the amniotic fluid was cultured using the amniomax C-100 GIBCO (Grand Island, NY, USA) medium for backup and confirmation. Apolipoprotein B (APO-B) and D1S80 variable number tandem repeat (VNTR) analyses were carried out to exclude maternal contamination as previously described (<xref rid="b8" ref-type="bibr">8</xref>). Sequencing analysis of the fetus&#x2019; DNA detected the codon 59 mutation but not the codon 24 mutation. DNA analysis using DNA extracted from cultured cells showed the same result.</p>
    <p>The affected child (II-2) has been suffering severe anemia since he was 3 years old (Hb 4.0&#x2009;g/dL), and required regular blood transfusions to maintain the steady state Hb at 6.6-8.4&#x2009;g/dL. However, his Hb level could decrease to as low as 4.5&#x2009;g/dL during infections. During the first year, he received regular blood transfusions every 8 weeks (3 years old), after which the frequency of blood tranfusions was increased to every 4 weeks. Iron chelation was initiated after he had received five tranfusions when the serum ferritin level reached 1059.6&#x2009;&#x3BC;g/L. A physical examination at 7 years old revealed splenomegaly (schuffner II) and liver enlargement (3&#x2009;cm). Sequencing results using forward and reverse primers revealed that this affected child was a compound heterozygote for the codon 24 and codon 59 mutations, both on the &#x3B1;2-globin gene (results not shown).</p>
    <p>We believe that the severe phenotype of this genetic compound heterozygosity can be explained by the increased hemolysis caused by the enhanced semi-hemizygous expression of the unstable Hb Adana due to the presence of the codon 24 defect in <italic>trans</italic>. Hb Adana is an unstable variant because the small and non polar glycine residue at &#x3B1;59 is internal and makes close spatial contact with the glycine residue at position &#x3B1;25 of the &#x3B2; helix replaced by the charged and larger aspartic acid residue. As previously described by C&#xFC;r&#xFC;k <italic>et al.</italic> (<xref rid="b12" ref-type="bibr">12</xref>), the Gly&#x2192;Asp replacement affects the stability of tertiary structure of the &#x3B1; subunit. Some cases of compound heterozygotes for Hb Adana and a deletional form of thalassemia mutation have been reported. Coinheritance of Hb Adana on the &#x3B1;2-globin gene and a two-gene deletion results in Hb H-like hydrops fetalis (<xref rid="b13" ref-type="bibr">13</xref>,<xref rid="b14" ref-type="bibr">14</xref>), whereas a similar case with Hb Adana on the &#x3B1;1-globin gene was reported as less severe in clinical manifestation (<xref rid="b12" ref-type="bibr">12</xref>,<xref rid="b15" ref-type="bibr">15</xref>). Compound heterozygotes for Hb Adana on the &#x3B1;2-globin gene and a one-globin gene deletion manifested as varied phenotypes (<xref rid="b9" ref-type="bibr">9</xref>,<xref rid="b16" ref-type="bibr">16</xref>), while the cases with a combination of Hb Adana and a nondeletional &#x3B1;-globin gene mutation is quite rare. However, in our experience, cases with this combination manifested quite severely compared to those cases with Hb Adana and deletional mutations (<xref rid="b9" ref-type="bibr">9</xref>). Hb Adana on the &#x3B1;2-globin gene is relatively frequent in Indonesia (<xref rid="b7" ref-type="bibr">7</xref>) with a frequency of about 16.0% in &#x3B1;-thal patient groups (<xref rid="b8" ref-type="bibr">8</xref>).</p>
    <p>The phenotype of the compound heterozygote for this novel codon 24 mutation and Hb Adana is not easy to predict. This new mutation located in exon 1 of the &#x3B1;2-globin gene results in a premature termination, which generated short mRNA that should be eliminated <italic>via</italic> nonsense-mediated decay (NMD) (<xref rid="b17" ref-type="bibr">17</xref>). The codon 24 mutation seems to be a mild &#x3B1;-thal defect that was confirmed by the hematological profile of the father similar to those observed in one &#x3B1;-globin gene deletion carriers (&#x2013;&#x3B1;/&#x3B1;&#x3B1;). Therefore the phenotype should be similar to those in cases with compound heterozygous Hb Adana and one &#x3B1;-globin gene deletion (<xref rid="b9" ref-type="bibr">9</xref>,<xref rid="b16" ref-type="bibr">16</xref>). Although the phenotype of compound heterozygotes for Hb Adana on the &#x3B1;2-globin gene and one &#x3B1;-globin gene deletion varied, most are mild (<xref rid="b9" ref-type="bibr">9</xref>). A severe phenotype present in the patient might be due to the activation of a cryptic splice site at the novel codon 24 mutation that may generate an abnormal &#x3B1;-globin chain. Further study is required to address this hypothesis.</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors thank the patients who were willing to be volunteers for this study, as well as Mewahyu Dewi (M. Biomed), Dr. Maria Dewi Indrawati and Dr. Widya Tirtha Kamandalu (The Eijkman Institute for Molecular Biology, Jakarta, Indonesia) for their helpful advice and encouragement during the preparation of this manuscript. The authors also sincerely thank Jan P. Schouten (MRC Holland) for providing the MLPA Kit and Al Harahap (Graduate Associate Teacher, Writing Program, University of Arizona, USA) for valuable comments, suggestions and proofreading the manuscript. Our thanks also to Dr. Baba Inusa [MRCP, FRCPCH, DCP (Haem), FMCPaed] (Evelina Children&#x2019;s Hospital, Guy&#x2019;s and St. Thomas&#x2019; National Health Service Foundation Trust, London, UK) for further suggestions and proofreading of the manuscript.</p>
    </ack>
    <sec id="ss2">
      <title>Declaration of interest</title>
      <p>The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Weatherall</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Clegg</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <source>The Thalassaemia Syndromes</source>
          <edition>4th</edition>
          <publisher-loc>Oxford</publisher-loc>
          <publisher-name>Blackwell Science</publisher-name>
          <year>2001</year>
        </element-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weatherall</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>The molecular basis for phenotypic variability of the common thalasssemias</article-title>
          <source>Mol Med Today.</source>
          <year>1995</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>15</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">9415132</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harteveld</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Higgs</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Review &#x3B1;-thalassaemia</article-title>
          <source>Orphanet J Rare Dis.</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>13</fpage>
          <pub-id pub-id-type="pmid">20507641</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liebhaber</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Cash</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Ballas</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Human &#x3B1;-globin gene expression: The dominant role of the &#x3B1;2-locus in mRNA and protein synthesis</article-title>
          <source>J Biol Chem.</source>
          <year>1986</year>
          <volume>261</volume>
          <issue>32</issue>
          <fpage>15327</fpage>
          <lpage>15333</lpage>
          <pub-id pub-id-type="pmid">3771577</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giordano</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Cnossen</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Joosten</surname>
              <given-names>AMS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Codon 24 (TA<italic>T</italic>&gt;TA<italic>G</italic>) and codon 32 (A<italic>T</italic>G&gt;A<italic>G</italic>G) (Hb Rotterdam): two novel &#x3B1;2 gene mutations associated with mild &#x3B1;-thalassemia found in the same family after newborn screening</article-title>
          <source>Hemoglobin.</source>
          <year>2010</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>354</fpage>
          <lpage>365</lpage>
          <pub-id pub-id-type="pmid">20642333</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Old</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>K</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Rapid detection of &#x3B1;-thalassaemia deletions and &#x3B1;-globin gene triplication by multiplex polymerase chain reactions</article-title>
          <source>Br J Haematol.</source>
          <year>2000</year>
          <volume>108</volume>
          <issue>2</issue>
          <fpage>295</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="pmid">10691858</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Setianingsih</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Harahap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nainggolan</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>Thalassemia in Indonesia: phenotypes and molecular defects</article-title>
          <source>Adv Exp Med Biol.</source>
          <year>2003</year>
          <volume>531</volume>
          <fpage>47</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">12916780</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nainggolan</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Harahap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Setianingsih</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Hydrops fetalis associated with homozygosity for Hb Adana [&#x3B1;59(E8)Gly&#x2192;Asp (&#x3B1;2)]</article-title>
          <source>Hemoglobin.</source>
          <year>2010</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>394</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">20642338</pub-id>
        </element-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nainggolan</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Harahap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ambarwati</surname>
              <given-names>DD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Interaction of Hb Adana (<italic>HBA2</italic>: c.179G&gt;A) with deletional and nondeletional &#x3B1;<sup>+</sup>-thalassemia mutations: diverse hematological and clinical features</article-title>
          <source>Hemoglobin.</source>
          <year>2013</year>
          <volume>37</volume>
          <issue>3</issue>
          <fpage>297</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">23614625</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dode</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rochette</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Krishnamoorthy</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Locus assignment of human &#x3B1; globin mutations by selective amplification and direct sequencing</article-title>
          <source>Br J Haematol.</source>
          <year>1990</year>
          <volume>76</volume>
          <issue>2</issue>
          <fpage>275</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="pmid">2094330</pub-id>
        </element-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molchanova</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Pobedimskaya</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Postnikov</surname>
              <given-names>YuV</given-names>
            </name>
          </person-group>
          <article-title>A simplified procedure for sequencing amplified DNA containing the &#x3B1;2- or &#x3B1;1-globin gene</article-title>
          <source>Hemoglobin.</source>
          <year>1994</year>
          <volume>18</volume>
          <issue>3</issue>
          <fpage>251</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">7928384</pub-id>
        </element-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#xC7;&#xFC;r&#xFC;k</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Dimovski</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Baysal</surname>
              <given-names>E</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Hb Adana or &#x3B1;<sub>2</sub>59(E8)Gly&#x2192;Asp&#x3B2;<sub>2</sub>, a severely unstable &#x3B1;1-globin variant, observed in combination with the &#x2013;(&#x3B1;)20.5 kb &#x3B1;-thal-1 deletion in two Turkish patients</article-title>
          <source>Am J Hematol.</source>
          <year>1993</year>
          <volume>44</volume>
          <issue>4</issue>
          <fpage>270</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="pmid">8237999</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>VW</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Molecular defects in Hb H hydrops fetalis</article-title>
          <source>Br J Haematol.</source>
          <year>1997</year>
          <volume>96</volume>
          <issue>2</issue>
          <fpage>224</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">9029003</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henderson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pitman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>J</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Molecular prenatal diagnosis of Hb H hydrops fetalis caused by Haemoglobin Adana and the implications to antenatal screening for &#x3B1;-thalassaemia</article-title>
          <source>Prenat Diagn.</source>
          <year>2008</year>
          <volume>28</volume>
          <issue>9</issue>
          <fpage>859</fpage>
          <lpage>861</lpage>
          <pub-id pub-id-type="pmid">18615546</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durmaz</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Akin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ekmekci</surname>
              <given-names>AY</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A severe &#x3B1;-thalassemia case compound heterozygous for Hb Adana in &#x3B1;1 gene and 20.5 kb double gene deletion</article-title>
          <source>J Pediatr Hematol Oncol.</source>
          <year>2009</year>
          <volume>31</volume>
          <issue>8</issue>
          <fpage>592</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">19636270</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Douna</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Papassotiriou</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Garoufi</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A rare thalassemic syndrome caused by interaction of Hb Adana [&#x3B1;59(E8)Gly&#x2192;Asp] with an &#x3B1;<sup>+</sup>thalassemia deletion: clinical aspects in two cases</article-title>
          <source>Hemoglobin.</source>
          <year>2008</year>
          <volume>32</volume>
          <issue>4</issue>
          <fpage>361</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="pmid">18654886</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khajavi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lupski</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease</article-title>
          <source>Eur J Hum Genet.</source>
          <year>2006</year>
          <volume>14</volume>
          <issue>10</issue>
          <fpage>1074</fpage>
          <lpage>1081</lpage>
          <pub-id pub-id-type="pmid">16757948</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
